Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease

Fig. 2

Relationship between plasma P1-immunoglobulin (IgM) levels and non-alcoholic fatty liver disease (NAFLD) upon further characterization of liver biopsies. a IgM titers towards P1 in controls and patients with NAFLD grouped based on their ALT levels. b Plasma IgM antibody titers against the P1 mimotope in patients with NAFLD in which the liver biopsy was evaluated and scored as simple steatosis versus non-alcoholic steatohepatitis (NASH). Anti-P1 IgM titers after scoring liver biopsies for c steatosis, d inflammation, e hepatocyte ballooning, f applying the NAFLD activity score (NAS), and g scoring fibrosis. Data are expressed in relative light units (RLU)/100 ms and presented as means. **p < 0.01

Back to article page